Chairman And Chief Executive Officer
CurrentCo-founded and organized BioSpherex starting in 1998 to develop and commercialize environmental microbiology technology, products, and services based on the emerging sciences of high throughput DNA sequencing. BioSpherex is an early pioneer in the emerging field of metagenomics specializing in functional and structural molecular analysis of microbial communities that we call now call “Metabiomics™”. Early research successes lead to development of advanced capillary electrophoresis and LH-PCR and Multitag Pyrosequencing ™ analytical methods (Patents Pending) for DNA assays of complex microbiota communities. Developed collaborative R&D programs with the the GMU Microbiome Analysis Center (MBAC), GMUComputational Sciences and Bioinformatics Center, and the Rush University Medical Center in 2003 to pursuehealth and medical research applications of Metabiomics™. Current pipeline of IVD and related therapeutic research is focused on dysbiosis of the human microbiome related to IDB, IBS, Obesity, HIV, Colon Cancer, and other human microbiome involved immunological, inflammatory, and polymicrobial diseases.